- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 7/02 - Recovery or purification
Patent holdings for IPC class C12N 7/02
Total number of patents in this class: 1087
10-year publication summary
|
52
|
66
|
72
|
65
|
80
|
71
|
58
|
68
|
51
|
30
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bavarian Nordic A/S | 267 |
22 |
| The Trustees of the University of Pennsylvania | 4406 |
18 |
| Cytiva BioProcess R&D AB | 320 |
11 |
| Transgene S.A. | 122 |
10 |
| Janssen Vaccines & Prevention B.V. | 278 |
9 |
| Sartorius Stedim Biotech GmbH | 869 |
9 |
| Valneva Austria GmbH | 119 |
9 |
| Novartis AG | 10341 |
8 |
| BIA Separations d.o.o. | 17 |
8 |
| Genzyme Corporation | 1342 |
8 |
| Seqirus UK Limited | 432 |
8 |
| Kaneka Corporation | 4643 |
7 |
| University of Florida Research Foundation, Inc. | 4154 |
7 |
| The Children's Hospital of Philadelphia | 848 |
7 |
| Crucell Holland B.V. | 81 |
7 |
| Takeda Vaccines, Inc. | 213 |
7 |
| Ultragenyx Pharmaceutical Inc. | 189 |
7 |
| uniQure Biopharma B.V. | 122 |
7 |
| uniQure IP B.V. | 89 |
7 |
| Merck Sharp & Dohme LLC | 3732 |
7 |
| Other owners | 904 |